ASTHENIA is the #10 most commonly reported adverse reaction for CAPECITABINE, manufactured by H2-Pharma, LLC. There are 3,322 FDA adverse event reports linking CAPECITABINE to ASTHENIA. This represents approximately 1.9% of all 174,965 adverse event reports for this drug.
Patients taking CAPECITABINE who experience asthenia should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
Reporting Frequency
ASTHENIA3,322 of 174,965 reports
ASTHENIA is a less commonly reported adverse event for CAPECITABINE, but still significant enough to appear in the safety profile.
Other Side Effects of CAPECITABINE
In addition to asthenia, the following adverse reactions have been reported for CAPECITABINE:
ASTHENIA has been reported as an adverse event in 3,322 FDA reports for CAPECITABINE. This does not prove causation, but indicates an association observed in post-market surveillance data.
How common is ASTHENIA with CAPECITABINE?
ASTHENIA accounts for approximately 1.9% of all adverse event reports for CAPECITABINE, making it a notable side effect.
What should I do if I experience ASTHENIA while taking CAPECITABINE?
If you experience asthenia while taking CAPECITABINE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.
Disclaimer: This analysis is based on FDA adverse event reports and is for informational purposes only. Reports do not prove causation. Always consult your healthcare provider.